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Abstract
Background: Neuroblastomas are the most common extracranial solid tumors in children. Neuroblastomas are derived from
immature cells of the sympathetic nervous system and are characterized by clinical and biological heterogeneity. Hypoxia
has been linked to tumor progression and increased malignancy. Intermittent hypoxia or repeated episodes of hypoxia
followed by re-oxygenation is a common phenomenon in solid tumors including neuroblastoma and it has a significant
influence on the outcome of therapies. The present study focuses on how intermittent hypoxia modulates the stem-like
properties and differentiation in neuroblastoma cells.
Methods and Findings: Cell survival was assessed by clonogenic assay and cell differentiation was determined by
morphological characterization. Hypoxia-inducible genes were analyzed by real-time PCR and Western blotting.
Immunofluorescence, real-time PCR and Western blotting were utilized to study stem cell markers. Analysis of neural
crest / sympathetic nervous system (SNS) markers and neuronal differentiation markers were done by real-time PCR and
Western blotting, respectively. Intermittent hypoxia stimulated the levels of HIF-1a and HIF-2 a proteins and enhanced
stem-like properties of neuroblastoma cells. In intermittent hypoxia-conditioned cells, downregulation of SNS marker genes
and upregulation of genes expressed in the neural crest were observed. Intermittent hypoxia suppressed the retinoic acid-
induced differentiation of neuroblastoma cells.
Conclusions: Our results suggest that intermittent hypoxia enhances stem-like characteristics and suppresses differentiation
propensities in neuroblastoma cells.
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Introduction
Neuroblastoma is the most common extracranial pediatric solid
tumor that is derived from the developing SNS and results from
the improper differentiation of neural crest cells [1,2]. Neuroblas-
tomas show a significant clinical heterogeneity ranging from
benign ganglioneuromas to highly aggressive immature tumors
with the likelihood of tumor progression varying widely according
to age and disease burden at diagnosis [3]. For high-risk
neuroblastoma patients, the prospect of long-term survival is
dismal despite intensive multimodal therapy [3]. Most solid tumors
exhibit regions of hypoxia as a result of inefficient vascular supply
by tumor vasculature and high oxygen consumption of rapidly
proliferating malignant cells [4–6]. Intermittent hypoxia [7–10],
which is characterized by cyclic periods of hypoxia and
reoxygenation, occurs in tumor cells that are dependent on tumor
blood vessels having intermittent perfusion fluctuations in blood
flow. The occurrence of intermittent hypoxic episodes varies
significantly in rapidly growing malignant tumors.
Hypoxia alters neuronal characteristics of human neuroblasto-
ma cells and promotes tumor phenotype with aggressive behavior
[11,12]. Intermittent hypoxia may be associated with generation of
a more invasive phenotype of tumor cells and tumor cell
dissemination [13–15]. Tumor cells that are intermittently hypoxic
may affect the response to therapy [9,16–18]. Neuroblastoma is
one of the few malignancies that demonstrate spontaneous
differentiation and regression to a benign state. Since neuroblas-
toma with unfavorable prognosis are poorly differentiated,
inducing tumor cells to differentiate is an important therapeutic
goal in neuroblastoma. In this study, we exposed human
neuroblastoma cells to intermittent hypoxia and examined the
impact of intermittent hypoxia on SNS progenitor markers, stem
cell-like phenotypes and differentiation. In our study, we found
that exposing neuroblastoma cells to intermittent hypoxia results
in a selection that is highly resistant to differentiation, and exhibits
immature neural crest-like and stem-like properties.
Materials and Methods
Materials
Anti-mouse Alexa 488, Anti-rabbit Alexa, 594, anti-mouse
CD133 were from Invitrogen (Carlsbad, CA). Anti-mouse HIF-1a
was from BD Biosciences (San Diego, CA). Anti-mouse HIF-2a
was from Novus Biochemicals (Littleton, CO). Antimouse c-kit was
from Santa Cruz (Santa Cruz, CA). Anti-mouse tyrosine
hydroxylase and b-actin were from Cell Signaling (Danvers,
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target plus non-targeting smart pool siRNA oligos were from
Dharmacon RNAi Technologies (Lafayette, CO). Anti-mouse
Neu-N was from Millipore (Bedford, MA). All-trans-retinoic acid
was from Sigma-Aldrich (St.Louis, MO). CD133/1-PE antibodies
were from Miltenyi Biotech (Auburn, CA). Rabbit anti-NF-M was
from Covance (Princeton, NJ).
Cell lines
NB1691, a MYCN and MDM2-amplified, chemoresistant [19]
human neuroblastoma cell line (provided by Peter Houghton, St.
Jude Children’s Research Hospital, Memphis, TN) was cultured in
DMEM supplemented with 10% heat-inactivated fetal bovine
serum and 100 units/mL penicillin, 100 mg/mL streptomycin at
37uCi n5 %C O 2 [20].
Exposures of cell cultures to intermittent hypoxia
treatment
NB1691 cells were exposed to 1, 5 or 10 cycles of hypoxia and
normoxia. Each cycle consisted of a period of 24 h in 1% hypoxia
followed by 24 h recovery under normoxic conditions. During the
reoxygenation period, the medium was changed.
Exposures of cell cultures to all-trans retinoic acid
treatment
Cells were treated with different concentration of all-trans
retinoic acid for 24 h and the procedure was performed under
dark conditions. No toxicity was observed in the cells due to
treatment.
Transfection of siRNAs
Cells were transfected with 40 nM siRNAs (control and HIF-1a)
using Fugene in six-multiwell plates. The cells harvested at 36 h
were lysed in cell lysis buffer (Cell Signaling, (Danvers, MA) to
obtain proteins for Western blotting analysis. Knockdown of HIF-
1a expression was confirmed by Western blot analysis.
SDS-PAGE and Western blot analysis
Cells were lysed in ice-cold lysis buffer solution containing
protease inhibitors and total proteins were extracted as described
previously [21]. Samples were subjected to SDS-PAGE and
separated proteins were transferred onto nitrocellulose membrane,
followed by blocking of membrane with 5% nonfat milk powder
(w/v) in Tris- buffered saline (10 mM Tris, 100 mM NaCl, 0.1%
Tween 20, pH 7.4) for 1 h at room temperature or overnight at
4uC. Membranes were probed using specific primary antibodies
followed by appropriate secondary antibody and enhanced
chemiluminescence visualization. Membranes were stripped and
reprobed with b-actin antibody as a protein loading control.
Nuclear and cytoplasmic extracts were prepared using the Active
Motif Nuclear Extraction kit (Active Motif, Carlsbad, CA)
according to the manufacturer’s instructions.
Real-time RT-PCR
Total RNA was extracted from cultured cells using TRIzol
reagent (Invitrogen, Carlsbad, CA) and reverse-transcribed using
the Transcriptor First Strand cDNA synthesis kit (Roche, USA)
following the instructions of the manufacturer. Quantitative real-
time-PCR reactions were performed in an iCycler iQ Real-Time
PCR Detection System (Bio-Rad, Hercules, CA) using the iQ
SYBR green supermix (Bio-Rad, Hercules, CA). Results of the
real-time PCR data were expressed as relative mRNA expression
quantified with Bio-Rad iCycler system software and normalized
to b-actin levels.
The forward and reverse primers used were:
HIF-1a, forward (TTCCAGTTACGTTCCTTCGATCA) and
reverse (TTTGAGGACTTGCGCTTTCA);
VEGF, forward (AGGAGGAGGGCAGAATCATCA) and
reverse (CTCGATTGGATGGCAGTAGCT);
Oct-4, forward (GAGAACCGAGTGAGAGGCAACC) and
reverse (CATAGTCGCTGCTTGATCGCT);
CD-133, forward (GCATTGGCATCTTCTATGGTT) and
reverse (CGCCTTGTCCTTGGTAGTGT);
Notch-1, forward (CCGCAGTTGTGCTCCTGAA) and
reverse (ACCTTGGCGGTCTCGTAGCT);
ID-2, forward (TCAGCCTGCATCACCAGAGA) and
reverse (CTGCAAGGACAGGATGCTGAT);
HES-1, forward (AGCGGGCGCAGATGAC) and
reverse (CGTTCATGCACTCGCTGAA);
Neuropeptide tyrosine (NPY), forward (TCCAGCCCAGAGA-
CACTGATT) and
reverse (AGGGTCTTCAAGCCGAGTTCT);
HASH-1, forward (GAGCAGCACACGCGTTATAGTAA)
and
reverse (GTGAAGGGACCCGAGCAA);
dHAND, forward (AGAGGAAGAAGGAGCTGAACGA) and
reverse (CGTCCGGCCTTTGGTTTT)
b-Actin, forward (AGAAGGATTCCTATGTGGGCG) and
reverse (CATGTCGTCCCAGTTGGTGAC).
Immunofluorescence
Cells were fixed for 30 min at 220uC in pre-chilled methanol
and permeabilized by 0.3% Triton X-100 in PBS. Cells were
incubated overnight at 4uC with the mouse anti-HIF1-a or mouse
anti-CD133 antibodies and subsequently incubated with second-
ary Alexa Fluor 488-conjugated anti-mouse or Alexa Fluor 594-
conjugated anti-mouse antibodies, respectively. DNA was visual-
ized by 49,6-diamidino-2-phenylindole (DAPI) staining. Fluoro-
chromes were visualized with Olympus microscope and imaged.
For dual immunofluorescence, incubation with mouse anti-HIF1a
and rabbit anti-NF-M was carried out. After washing, cells were
incubated with Alexa Fluor 488-conjugated anti-mouse and Alexa
Fluor 594-conjugated anti-rabbit IgG secondary antibodies.
Finally, cells were counterstained with DAPI for nucleus. Cells
were observed under Olympus fluorescent microscope.
Clonogenic assay
Cells were trypsinized, plated into 100-mm dishes, and
incubated at 37uC in a humidified incubator containing 5%
CO2. After 15 days, cells were stained with crystal violet and
colonies having .50 cells were counted as surviving colonies.
Flow Cytometric analysis
To determine the surface expression of CD133, cells were
detached and incubated with the CD133/1-PE antibodies
(Miltenyi Biotech, Auburn, CA) according to the manufacturer’s
instructions. After washing, flow cytometric analysis was done
using FACScan (BD Biosciences, San Diego, CA). IgG-PE
antibody was used as a control.
Neurite measurements
Cell morphology was examined at 24 h after 5 mM retinoic acid
treatment of human neuroblastoma cells. Cells were considered
differentiated if they had one neurite longer than the control group
mean neurite length. The length of the longest neurite was
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magnification) for each treatment group. Phase-contrast images
were taken under bright field using an Olympus CKX41 inverted
microscope.
Statistical analysis
The statistical significance of differences between data sets was
determined by using Student’s t- test. P values less than 0.05 were
regarded as significant and were marked with (*) and P,0.01
marked with (**).
Results
Regulation of HIF-1a expression in intermittent hypoxia-
conditioned neuroblastoma cells
We examined the impact of intermittent hypoxia on the
abundance of HIF-1a. Intermittent hypoxia-conditioned cells were
derived from NB1691 cells that were exposed to 10 cycles of
hypoxia and reoxygenation. Each cycleconsisted ofa periodof 24 h
in hypoxia (1% O2) followed by 24 h recovery under normoxic
conditions. Real-time PCRs were done using primers specific to
HIF-1a and b-actin. Intermittent hypoxia induced an increase in
the abundance of HIF-1a transcript accumulation despite the
reoxygenation phases (Fig. 1A and Fig. S1). We also examined the
expression of HIF-1a protein by immunofluorescence and immu-
noblot analyses. Immunofluorescence studies have shown an
increase in the levels of HIF-1a protein in hypoxic and intermittent
hypoxia-conditioned cells (Fig. 1C). HIF-1a protein is mostly found
in the nucleus of intermittent hypoxia-conditioned cells. Immuno-
blotting experiments revealed that the increase in HIF-1a mRNA
transcript observed in response to intermittent hypoxia (Fig. 1A) did
translate into an upregulation of protein expression (Fig.1B). An
increase in the expression of HIF-2a protein was observed in
intermittent hypoxia conditioned human neuroblastoma cells
(Fig.1D).Theseresultsindicatethatintermittenthypoxia stimulated
the expression of HIF-1a and HIF-2a proteins in NB1691 cells.
Induction of known hypoxia-inducible genes
HIF-1a/b complexes interact with the HIF-responsive element
(HRE) of a large number of target genes including VEGF. We
therefore used real-time PCR to analyze the expression of VEGF
in response to intermittent hypoxia. The expression in intermittent
hypoxia versus normoxia control samples shows that VEGF
mRNA transcript is up-regulated in NB1619 cells (Fig. 2A).
Effect of intermittent hypoxia on tumor cell survival
We next used a clonogenic assay to evaluate the effects of
intermittent hypoxia. We observed a dramatic gain in survival of
intermittent hypoxia conditioned NB1691 cells compared with
cells maintained in normoxia (Fig. 2B).
Figure 1. Regulation of HIF-1a expression in intermittent hypoxia-conditioned human neuroblastoma cells. Cells were grown under
normoxic conditions (N) or exposed to 1% O2 for 24 h (H). Intermittent hypoxia-conditioned cells were derived from NB1691 cells that were exposed
to 10 cycles of hypoxia (1% O2, 24 h) and reoxygenation. (A) Real-time PCR. Total RNA was extracted from neuroblastoma cells using Trizol and cDNA
was generated by reverse transcription. Real-time PCRs were done using primers specific to HIF-1a and b-actin. **P,0.01 hypoxia or intermittent
hypoxia versus normoxia. (B) Cell extracts were assessed for HIF-1a and b-actin by immunoblotting. (C) Immunofluorescence. Cells were fixed in ice-
cold methanol for 20 min at 220uC. Then, cells were labeled with HIF-1a antibodies and Alexa-488 antimouse-conjugated antibodies.
Photomicrographs were taken using Olympus fluorescence microscope. Nuclei were stained with DAPI (bar, 100 mm). (D) Cell lysates were probed for
HIF-2a and b-actin by western blotting.
doi:10.1371/journal.pone.0030905.g001
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Hypoxia has been implicated in promoting tumor growth [22–
24]. Evidence of stem-like cancer cells has been established in
various types of cancer, including neuroblastoma [25–27]. Since it
has been reported that hypoxia exposure alone can increase the
stem-like cell population, studies were performed to determine
whether intermittent hypoxia would upregulate the expression of
stem cell-associated genes in neuroblastoma cells. Using the real-
time PCR analysis, we found that the intermittent hypoxia-
selected subpopulation displayed an increase in gene transcripts of
stem cell markers Oct-4 (Fig. 3A) and CD133 (Fig. 3B) in
comparison with the normoxic cells. Further, immunofluorescence
and flow cytometry analyses, have confirmed the upregulation of
CD133 expression in intermittent hypoxia-conditioned tumor cells
(Fig. S2 and Fig. 3C and D). Thus, our data suggest that
intermittent exposures of hypoxia and reoxygenation cause
enrichment of neuroblastoma cells with stem-like properties.
Intermittent hypoxia and expression of neural crest /
sympathetic nervous system markers
Hypoxia has been linked to creation of a microenvironment
enriched in poorly differentiated tumor cells [28]. HIF-1a and
HIF-2a have been linked to an aggressive tumor phenotype by
promoting the processes essential for tumor growth as well as
blocking differentiation [29,30]. Studies were performed to
determine whether intermittent hypoxia modulates the expression
of neural crest genes. Immunoblot analysis has shown elevated
expression levels of tyrosine hydroxylase(TH) and c-Kit proteins in
intermittent-hypoxia conditioned cells (Fig. 4A). As further
evidence, real-time PCR analysis demonstrated an increase in
transcripts of neural crest markers Notch-1, ID2 and HES-1in
intermittent hypoxia-conditioned cells (Fig. 4B, C, D). We also
studied the effects of intermittent hypoxia on the differentiation
status of neuroblastoma cells by examining the expression of the
sympathetic neuronal peptide neurotransmitter gene, NPY. The
expression levels of HASH-1 and dHAND genes that are
associated in early sympathetic lineage specification were deter-
mined by real-time PCR. Our results show that the expression
levels of NPY, HASH-1and dHAND were found decreased in
intermittent hypoxia conditioned tumor cells (Fig. 4E,F,G). These
observations reveal that intermittent hypoxia-exposed cultured
human neuroblastoma cells exhibit downregulation of SNS
marker genes, such as the neurofilament genes NPY, HASH-1
and dHAND, as well as upregulation of genes expressed in the
neural crest, e.g., ID2, HES-1, c-Kit and Notch-1.
Effect of retinoic acid on neuroblastoma cells
It has been known that neuroblastoma cells can be induced to
differentiate into neuron-like cells by retinoic acid [31,32]. We
sought to examine the effects of retinoic acid on neuronal
properties. Here NB1691 cells were treated with various
concentrations of retinoic acid and investigated for the expression
of neuronal markers including Neu N and NF-M. Protein levels of
neuronal markers in untreated and retinoic acid treated NB1691
cells were compared by Western blot analysis (Fig. S3). We
observed a significant increase in the expression of NF-M and Neu
N in NB1691 cells differentiated upon retinoic acid treatment.
Hypoxia reduced the levels NF-M and Neu N proteins induced by
retinoic acid in neuroblastoma cells. HIF-1a levels increased under
hypoxia; however retinoic acid reduced hypoxia-induced HIF-1a
(Fig. S3).
Next, neuroblastoma cells were treated with retinoic acid and
the cell morphology was examined. Fig. 5A shows extension of
neurites, a typical neuronal phenotype suggesting that NB1691
cells undergo differentiation upon treatment with retinoic acid. An
analysis of morphological differentiation was obtained by measur-
ing neurite length (Fig. 5A). The mean neurite length was
significantly reduced in intermittent hypoxia-conditioned cells
(Fig. 5B). Further, the potentiation of neuronal differentiation by
retinoic acid was significantly less in intermittent hypoxia-
conditioned cells compared with the cells maintained in normoxia.
To confirm the changes in the expression of neuronal markers
revealed by western-blot analysis, an indirect double-immunoflu-
orescence stain with anti-NF-M and anti- HIF-1a was performed
in NB1691 cells with and without retinoic acid treatment.
Fluorescent intensity of NF-M and HIF-1a was compared between
parental and retinoic acid treated NB1960 cells (Fig. 5C). We
observed a significant increase in fluorescent intensity in NF-M
and a decrease in the intensity of HIF-1a in cells treated with
retinoic acid. Intermittent hypoxia conditioned cells exhibit
decreased NF-M intensity and higher HIF-1a intensity compared
with control. No significant changes in the intensity of NF-M and
Figure 2. Effects of intermittent hypoxia on VEGF, a hypoxia-response gene and cell survival. (A) Real-time PCR. Total RNA was extracted
from normoxic (N), and intermittent hypoxia (IH) conditioned neuroblastoma cells using Trizol and cDNA was generated by reverse transcription.
Real-time PCRs were done to measure VEGF gene transcript. **P,0.01, intermittent hypoxia versus normoxia. (B) Clonogenic assay. Cells were
trypsinized, plated into 100-mm dishes, and incubated at 37uC in a humidified incubator containing 5% CO2. After 15 days, cells were stained with
crystal violet and colonies having .50 cells were counted as surviving colonies. **P,0.01, intermittent hypoxia versus normoxia.
doi:10.1371/journal.pone.0030905.g002
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(A, B) Real-time PCR analysis was performed in normoxic (N), and intermittent hypoxia (IH) conditioned neuroblastoma cells using primers specific to
Oct-4 and CD133, and normalized to b-actin transcripts. **P,0.01, intermittent hypoxia versus normoxia. (C) Immunofluorescence analysis of CD133
expression. Cells were fixed and labeled with CD133 antibodies and Alexa-488 antimouse-conjugated antibodies. Photomicrographs were taken
using Olympus fluorescence microscope. Nuclei were stained with DAPI (bar, 100 mm). (D) Flow cytometry. Cells were incubated with CD133/1-PE
antibodies according to the manufacturer’s instructions to determine the surface expression of CD133. After washing, flow cytometry was done using
FACScan. IgG-PE antibody was used as a control. A representative flow cytometry analysis is shown. The graph represents the results of experiment
done in triplicate.
doi:10.1371/journal.pone.0030905.g003
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treated with retinoic acid (Fig. 5D).
To validate the changes in the expression of neuronal markers
revealed by immunocytochemical studies, western blot analysis
was then performed. A decrease in NF-M and Neu N was found in
intermittent hypoxia-conditioned cells. Retinoic acid upregulated
NF-M and Neu N protein levels in normoxic cells; however, no
increase was observed in intermittent hypoxia-conditioned cells
(Fig. 5E).
Effect of HIF-1a knockdown on differentiation of
neuroblastoma cells
We addressed the possible role of the IH on differentiation of
neuroblastoma cells. To analyze the role of the HIF-1a in the
regulation of differentiation of neuroblastoma cells, the HIF-1a
was silenced by transfection of specific HIF-1a siRNA. The
efficiency of siRNA knock-down was assessed by immunoblotting
with antibodies against HIF-1a. As expected, the HIF-1a protein
was markedly reduced in the siRNA-transfected cells. An analysis
of morphological differentiation has shown an increase in
neuronal differentiation in intermittent hypoxia-conditioned cells
treated with HIF-1a siRNA under hypoxia (Fig. 6A, B). To
further explore the effect of the HIF-1a on differentiation, we
investigated the protein levels of Neu N and NF-M. As expected,
an increase in NF-M and Neu N protein levels were found in
intermittent hypoxia-conditioned cells treated with HIF-1a
siRNA (Fig. 6C).
Discussion
Neuroblastic tumors are characterized by extreme clinical and
pathological heterogeneity [33]. Hypoxia is widespread in solid
tumors as a consequence of microregional fluctuations in perfusion
as well as poorly structured tumor vasculature [4–6]. Like other
solid tumor cells, neuroblastoma cells are able to adapt to hypoxia
by modulating their phenotype. Intermittent hypoxia is described
as a more representative picture of the oxygen tension of the
environment in tumors rather than a permanent exposure to low
oxygen levels. Many previous studies focused on acute or chronic
hypoxia, but intermittent hypoxia also plays an important role in
solid tumors. Metastasis-associated genes were found significantly
upregulated in hypoxic cells sorted from tumors of intermittent
hypoxia treated mice compared with hypoxic cells derived from
tumors exposed to normoxia [34].
The effects of intermittent hypoxia on neuroblastoma cells
remain unclear needing further investigations. Hypoxia, when
followed by reoxygenation has been demonstrated to induce
oxidative stress in cancer cells and promotes tumor development
[35,36]. Tumor cells have been exposed to a wide range of periods
of hypoxia from hours to days in various cell culture studies of
intermittent hypoxia [13,37–41]. Our protocol of intermittent
hypoxia was also based on other cell culture studies and we
selected a sequence of hypoxic and normoxic intervals of 24 h in
an effort to replicate the hypoxic-resistant intratumoral environ-
ment in vitro.
Expression of HIF-1a increased progressively after at 5 and 10
cycles of hypoxia and reoxygenation as evidenced by immuno-
blotting data (Fig. S1). Studies have shown that the reoxygenation
of hypoxic tumor cells can also result in free radical formation,
leading to the nuclear accumulation of HIF-1a [42]. The nuclear
accumulation of HIF-1a under intermittent hypoxia could explain
the increase in HIF-1 transcriptional activity as observed by the
increase in target gene mRNA levels such as VEGF which is
associated with tumor angiogenesis [43]. Different roles of HIF-1a
Figure 4. Effects of intermittent hypoxia on neural crest /SNS markers. Upregulation of markers for neural crest genes. (A) Western Blotting.
Cell lysates of normoxic (N) and intermittent hypoxia (IH) conditioned neuroblastoma cells were analyzed by western blotting for the levels of c-Kit
and TH. Real-time PCR. PCR analysis was performed in normoxic (N) and intermittent hypoxia (IH) conditioned neuroblastoma cells using primers
specific to Notch-1 (B), ID2 (C) and HES-1(D) gene transcripts. **P,0.01, intermittent hypoxia versus normoxia. Downregulation of SNS markers. Real-
time PCR. PCR analysis was performed in normoxic (N) and intermittent hypoxia (IH) conditioned neuroblastoma cells using primers specific to NPY
(E), HASH-1(F) and dHAND (G). **P,0.01, intermittent hypoxia versus normoxia.
doi:10.1371/journal.pone.0030905.g004
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in various cell types [44,45]. In our study, it was found that, like
HIF-1a, HIF-2a level was also increased. Our observation of an
increased expression of HIF-2 a in response to intermittent
hypoxia in neuroblastoma cells is in agreement with other studies
showing induction of HIF-2a by hypoxia [11,46]. However,
Holmquist et al [38] have shown that prolonged hypoxia
diminishes HIF-1a protein. This inconsistency could be explained
either by difference in cell type, or by different mechanisms
switched on during intermittent hypoxia in comparison to chronic
hypoxia. Clonogenic assay reveals an increased survival of
intermittent hypoxia-conditioned neuroblastoma cells. These
results support that the stabilization of HIF-1a and HIF-2a
enhanced tumor cell survival under intermittent hypoxia.
We next examined the influence of intermittent hypoxia on
enhancement of stem-like properties of cells. Our real-time PCR
analysis revealed an increase in the expression of stem cell markers
CD133 and Oct-4 in intermittent hypoxia conditioned cells
compared with cells grown under normoxia. Both Immunofluo-
rescence and flow cytometry analysis also confirmed the
upregulation of CD133 in intermittent hypoxia conditioned cells.
Further, we observed CD133 expression is localized in membrane
and cytosolic compartments of tumor cells. By immunohistochem-
ical staining, Tong et al [47] have reported that CD133 was
mainly expressed in the cytoplasm of tumor cells of neuroblastoma
patients. Studies have shown that hypoxia can drive a phenotype
that can increase the stem-like phenotype or the number of stem-
like cancer cells to ensure survival of the tumor [26,27,48].
Figure 5. Effect of retinoic acid on human neuroblastoma cells. (A) Normoxic (N) and intermittent hypoxia (IH) conditioned neuroblastoma
cells were treated with 5 mm retinoic acid for 24 h and cell morphology was examined. Phase-contrast images were taken under bright field using an
Olympus CKX41 inverted microscope (bar, 50 mm). (B) Graphic illustration of quantification of neurite lengths of normoxic and intermittent-hypoxia
conditioned neuroblastoma cells treated with 5 mm retinoic acid. *P,0.05 **P,0.01, retinoic acid-treated versus untreated. (C) Immunofluorescence.
Cells were fixed and incubated with primary antibodies for NF-M or HIF-1a. Then cells were washed in PBS and incubated with secondary antibodies,
Alexa Fluor 488-conjugated anti-mouse IgG (HIF-1a) or Alexa Fluor 594-conjugated anti-rabbit IgG (NF-M) (bar, 100 mm). (D)D u a l
Immunofluorescence. Cells were treated with 10 mM retinoic acid for 24 h fixed and incubated with primary antibodies for NF-M or HIF-1a. Then
cells were washed in PBS and incubated with secondary antibodies, Alexa Fluor 488-conjugated anti-mouse IgG or Alexa Fluor 594-conjugated anti-
rabbit IgG. Nuclei were stained with DAPI. Photomicrographs were taken using Olympus fluorescence microscope (bar, 100 mm). (E) Western blotting:
Cells were treated with 10 mM retinoic acid for 24 h. Cell lysates were analyzed for the levels of HIF-1a, NF-M and Neu N proteins by western blotting.
b-actin served as loading control.
doi:10.1371/journal.pone.0030905.g005
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positive cancer stem cell expansion in gliomas [49]. It has been
shown that HIF-2a protein is expressed consistently higher in
glioma stem cells than in matched non-stem cancer cells or normal
neural progenitors indicating that HIF-2a induction is restricted to
cancer stem cells [50]. Our results support that intermittent hypoxia
could expand selectively stem-like subpopulation in the neuroblas-
toma cells in part through upregulation of HIF-1a and HIF-2a.
Neuroblastoma cell lines exhibit many of the cell phenotypes
characteristic of the developing neural crest cells such as cellular
heterogeneity, plasticity and transdifferentiation capacity [51]. In
our studies, crest cell markers such as c-kit, Notch-1, HES-1, and
ID2 were found to be increased reflecting immature state in cells
exposed to intermittent hypoxia. Interestingly, Notch1, ID2, and
HES1 were proposed as mediators of dedifferentiation. The Notch
signaling pathway has been shown to inhibit neuroblastoma tumor
cell differentiation [52] and Notch1 expression has been shown to
be associated with high-risk tumor features and poor prognosis in a
cohort of children with neuroblastoma [53]. The expression of
genes immediately downstream of Notch, such as HES [54] was
altered by hypoxia. [55]. It has been shown that ID2 is involved in
normal neural crest development. Hypoxia induces ID2 expres-
sion and hypoxia-induced ID2 expression play a significant role in
dedifferentiation of hypoxic neuroblastoma cell [56]. Intermittent
hypoxia also caused a decrease in the expression of SNS neuronal
lineage-specific marker genes, including NPY, Hash-1 and
dHAND. Others have reported that neuroblastoma cells lost their
neuronal/ neuroendocrine features and gained immature, neural
crest-like phenotype upon exposure to hypoxia [38,57].
Induced differentiation of transformed cells into mature
phenotypes represents a promising strategy in recent antitumor
therapy .The treatment of neuroblastoma patients with retinoids
during maintenance therapy has increased survival rates [58,59].
In the current study, we identified a role for intermittent hypoxia
in retinoic acid-mediated induction of neuronal differentiation in
neuroblastoma cells. We observed that a decrease in differentiation
was observed in retinoic acid-treated cells exposed to intermittent
hypoxia accompanied by reduced neurite outgrowth and the
suppression of neuronal differentiation markers, NF-M and Neu
N. On the other hand, inhibition of HIF-1a expression by
transfection of HIF-1 siRNA promoted neuronal differentiation in
intermittent hypoxia conditioned cells as measured by up-
regulation of NF-M and Neu N, as well as morphological changes.
Our results suggest that HIF-1a plays a marked role in suppressing
retinoic acid-induced differentiation of neuroblastoma cells
exposed to intermittent hypoxia.
Taken together, multiple cycles of hypoxia and reoxygenation
provide selective advantage to neuroblastoma cells and can lead to
complex changes which are associated with enhanced stem-like
features, immature neural-crest-line phenotype and decreased
retinoic acid-induced differentiation. Indeed, targeting oxygen
response pathways, such as HIF-1a and HIF-2a, are promising
strategies for suppressing neuroblastoma development and im-
proving outcomes of therapies.
Supporting Information
Figure S1 HIF-1a expression in intermittent hypoxia-
conditioned neuroblastoma cells. Intermittent hypoxia-
conditioned cells were derived from NB1691 cells that were
exposed to 1, 5 or10 cycles of hypoxia and reoxygenation. Each
cycle consisted of a period of 24 h in hypoxia (1% O2) followed by
Figure 6. Effect of HIF-1a siRNA on differentiation of human neuroblastoma cells. (A) Normoxic (N) and intermittent hypoxia (IH)
conditioned neuroblastoma cells were treated with non-targeted control (NTC) or HIF-1a siRNA smart pool for 36 h and phase-contrast images were
taken under bright field using an Olympus CKX41 inverted microscope (bar, 50 mm). (B) Graph illustrates quantification of neurite lengths of cells
treated with NTC or HIF-1a siRNA. **p,0.01, intermittent hypoxia conditioned cells treated with HIF-1a siRNA versus NTC or untreated. (C) Western
blotting. Cells were treated with NTC or HIF-1a siRNA smart pool. After 36 h, cells were lysed and cell extracts were subjected to western blotting
analysis for HIF-1a, NF-M and Neu N.
doi:10.1371/journal.pone.0030905.g006
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assessed for HIF-1a and b-actin by western blotting.
(TIF)
Figure S2 Dual Immunofluorescence. Normoxic (N) and
intermittent hypoxia (IH) conditioned neuroblastoma cells were
incubated with primary antibodies for CD133 or HIF-1a. Then
cells were washed in PBS and incubated with secondary
antibodies, Alexa Fluor 488 or 594-conjugated anti-mouse IgG.
Nuclei were stained with DAPI (bar, 100 mm).
(TIF)
Figure S3 Effect of retinoic acid on human neuroblas-
toma cells. Western blotting: NB1691 cells were treated with
various concentrations of retinoic acid for 24 h under hypoxia or
normoxia. Cell lysates were analyzed for the levels of HIF-1a, NF-
M and Neu N proteins by western blotting.
(TIF)
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